Germing U - Search Results

1

Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.

Pleyer L, Germing U, Sperr WR, Linkesch W, Burgstaller S, Stauder R, Girschikofsky M, Schreder M, Pfeilstocker M, Lang A, Sliwa T, Geissler D, Schlick K, Placher-Sorko G, Theiler G, Thaler J, Mitrovic M, Neureiter D, Valent P, Greil R. Pleyer L, et al. Among authors: germing u. Leuk Res. 2014 Apr;38(4):475-83. doi: 10.1016/j.leukres.2014.01.006. Epub 2014 Jan 18. Leuk Res. 2014. PMID: 24522248 Free article.

2

Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.

Aul C, Gattermann N, Heyll A, Germing U, Derigs G, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1992 Jan;6(1):52-9. Leukemia. 1992. PMID: 1736014

3

Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score.

Aul C, Gattermann N, Germing U, Runde V, Heyll A, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1994 Nov;8(11):1906-13. Leukemia. 1994. PMID: 7967735

4

Fatal hyperleukocytic syndrome in a patient with chronic myelomonocytic leukemia.

Aul C, Gattermann N, Germing U, Südhoff T, Hollmig KA, Heyll A. Aul C, et al. Among authors: germing u. Leuk Res. 1997 Mar;21(3):249-53. doi: 10.1016/s0145-2126(96)00117-8. Leuk Res. 1997. PMID: 9111170

5

Increasing incidence of myelodysplastic syndromes: real or fictitious?

Aul C, Germing U, Gattermann N, Minning H. Aul C, et al. Among authors: germing u. Leuk Res. 1998 Jan;22(1):93-100. doi: 10.1016/s0145-2126(97)00089-1. Leuk Res. 1998. PMID: 9585086

6

Problems in the classification of CMML--dysplastic versus proliferative type.

Germing U, Gattermann N, Minning H, Heyll A, Aul C. Germing U, et al. Leuk Res. 1998 Oct;22(10):871-8. doi: 10.1016/s0145-2126(97)00192-6. Leuk Res. 1998. PMID: 9766745

7

Pericardial effusion in chronic myelomonocytic leukemia (CMML): a case report and review of the literature.

Strupp C, Germing U, Trommer I, Gattermann N, Aul C. Strupp C, et al. Among authors: germing u. Leuk Res. 2000 Dec;24(12):1059-62. doi: 10.1016/s0145-2126(00)00078-3. Leuk Res. 2000. PMID: 11077120 Review.

8

Thalidomide for the treatment of patients with myelodysplastic syndromes.

Strupp C, Germing U, Aivado M, Misgeld E, Haas R, Gattermann N. Strupp C, et al. Among authors: germing u. Leukemia. 2002 Jan;16(1):1-6. doi: 10.1038/sj.leu.2402330. Leukemia. 2002. PMID: 11840256

9

Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.

Strupp C, Gattermann N, Giagounidis A, Aul C, Hildebrandt B, Haas R, Germing U. Strupp C, et al. Among authors: germing u. Leuk Res. 2003 May;27(5):397-404. doi: 10.1016/s0145-2126(02)00220-5. Leuk Res. 2003. PMID: 12620291

10

Risk assessment in chronic myelomonocytic leukemia (CMML).

Germing U, Kündgen A, Gattermann N. Germing U, et al. Leuk Lymphoma. 2004 Jul;45(7):1311-8. doi: 10.1080/1042819042000207271. Leuk Lymphoma. 2004. PMID: 15359628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters